Resolution of the Council of experts in obstetrics and gynecology «New possibilities of luteal phase support with progesterone preparations in the framework of import substitution». April 25, 2023, Moscow

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

25 апреля 2023 г. состоялся экспертный совет, посвященный оптимизации методов поддержки лютеиновой фазы в программах вспомогательных репродуктивных технологий (ВРТ) в условиях импортозамещения.

全文:

受限制的访问

作者简介

Irina Korneeva

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

编辑信件的主要联系方式.
Email: aig@oparina4.ru

Expert, Dr. Med. Sci., Professor, Senior Researcher, F. Paulsen Department of Fertility Preservation and Restoration

俄罗斯联邦, Moscow

Dilorom Kamilova

MC GC «Mother and Child»

Email: aig@oparina4.ru

PhD, Member of the Russian Association of Human Reproduction, Member of the American and European Associations of Reproductive Medicine

俄罗斯联邦, Moscow

Natalya Tapilskaya

Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia; D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductive Medicine

Email: aig@oparina4.ru

Dr. Med. Sci., Professor, Leading Researcher at the Department of Reproduction, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Professor at the Department of Obstetrics and Gynecology, St. Petersburg State Pediatric Medical University, Ministry of Health of the Russia

 

俄罗斯联邦, St. Petersburg; St. Petersburg

Elena Mayasina

LLC «Clinical Institute of Reproductive Medicine»

Email: aig@oparina4.ru

PhD, obstetrician-gynecologist, Deputy General Director

俄罗斯联邦, Yekaterinburg

Larisa Fatkullina

Kazan State Medical University, Ministry of Health of Russian Federation

Email: aig@oparina4.ru

PhD, Associate Professor, Department of Obstetrics and Gynecology named after Prof. V.S. Gruzdev, Chief Freelance Specialist in Obstetrics and Gynecology of Kazan Department of Health of Ministry of Health of the Republic of Tatarstan

俄罗斯联邦, Kazan

Angelina Chibisova

Tula State University, Medical Institute; Lapino Clinical Hospital of the Mother and Child Group of Companies “HAVEN” LLC

Email: aig@oparina4.ru

PhD, Associate Professor, Department of Obstetrics and Gynecology, obstetrician-gynecologist, Chief Physician of MC GK «Mother and Child»

俄罗斯联邦, Tula; Moscow Region

Galina Garaeva

LLC «Clinic NGC»

Email: aig@oparina4.ru

obstetrician-gynecologist, reproductologist, Head of the Department of ART

俄罗斯联邦, Ufa

Lyudmila Lazareva

Family Health and Human Reproduction

Email: aig@oparina4.ru

PhD, obstetrician-gynecologist, gynecologist-endocrinologist, Research Center for Problems

俄罗斯联邦, Irkutsk

参考

  1. van der Linden M., Buckingham K., Farquhar C., Kremer J.A., Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst. Rev. 2015; 2015(7): CD009154. https://dx.doi.org/10.1002/ 14651858.CD009154.pub3.
  2. Di Renzo G.C., Tosto V., Tsibizova V. Progesterone: History, facts, and artifacts. Best Pract. Res. Clin. Obstet. Gynaecol. 2020; 69: 2-12. https://dx.doi.org/10.1016/j.bpobgyn.2020.07.012.
  3. Piette P. The history of natural progesterone, the never-ending story. Climacteric. 2018; 21(4): 308-14. https://dx.doi.org/10.1080/13697137.2018.1462792.
  4. Large M.J., DeMayo F.J. The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling. Mol. Cell Endocrinol. 2012; 358(2): 155-65. https://dx.doi.org/10.1016/j.mce.2011.07.027.
  5. Labarta E., Rodríguez C. Progesterone use in assisted reproductive technology. Best Pract. Res. Clin. Obstet. Gynaecol. 2020; 69: 74-84. https://dx.doi.org/ 10.1016/j.bpobgyn.2020.05.005.
  6. Rosenberg S.M., Luciano A.A., Riddick D.H. The luteal phase defect: the relative frequency of, and encouraging response to, treatment with vaginal progesterone. Fertil. Steril. 1980; 34(1): 17-20. https://dx.doi.org/10.1016/s0015-0282(16)44831-4.
  7. Labarta E., Mariani G., Holtmann N., Celada P., Remohí J., Bosch E. Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study. Hum. Reprod. 2017; 32(12): 2437-42. https://dx.doi.org/10.1093/humrep/dex316. Erratum in: Hum. Reprod. 2018; 33(1): 178.
  8. Labarta E., Mariani G., Paolelli S., Rodriguez-Varela C., Vidal C., Giles J. et al. Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in artificial cycles with vaginal progesterone. Hum. Reprod. 2021; 36(3): 683-92. https://dx.doi.org/10.1093/humrep/deaa322.
  9. Melo P., Chung Y., Pickering O., Price M.J., Fishel S., Khairy M. et al. Serum luteal phase progesterone in women undergoing frozen embryo transfer in assisted conception: a systematic review and meta-analysis. Fertil. Steril. 2021; 116(6): 1534-56. https://dx.doi.org/10.1016/j.fertnstert.2021.07.002.
  10. Pabuçcu E., Pabuçcu R., Gürgan T., Tavmergen E. Luteal phase support in fresh and frozen embryo transfer cycles. J. Gynecol. Obstet. Hum. Reprod. 2020: 101838. https://dx.doi.org/10.1016/j.jogoh.2020.101838.
  11. Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L., Sauer M.V. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil. Steril. 1994; 62(3): 485-90. https://dx.doi.org/10.1016/s0015-0282(16)56935-0.
  12. Tavaniotou A., Smitz J., Bourgain C., Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum. Reprod. Update. 2000; 6(2): 139-48. https://dx.doi.org/10.1093/humupd/6.2.139.
  13. de Ziegler D., Sator M., Binelli D., Leuratti C., Cometti B., Bourgain C. et al. A randomized trial comparing the endometrial effects of daily subcutaneous administration of 25 mg and 50 mg progesterone in aqueous preparation. Fertil. Steril. 2013; 100(3): 860-6. https://dx.doi.org/10.1016/j.fertnstert.2013.05.029.
  14. Ovarian Stimulation TEGGO, Bosch E., Broer S., Griesinger G., Grynberg M., Humaidan P., Kolibianakis E. et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum. Reprod. Open. 2020; 2020(2): hoaa009. https://dx.doi.org/10.1093/hropen/hoaa009. Erratum in: Hum. Reprod. Open. 2020; 2020(4): hoaa067.
  15. Shoham G., Leong M., Weissman A. A 10-year follow-up on the practice of luteal phase support using worldwide web-based surveys. Reprod. Biol. Endocrinol. 2021; 19(1): 15. https://dx.doi.org/10.1186/s12958-021-00696-2.
  16. Di Guardo F., Midassi H., Racca A., Tournaye H., De Vos M., Blockeel C. Luteal phase support in IVF: comparison between evidence-based medicine and real-life practices. Front. Endocrinol (Lausanne). 2020; 11: 500. https://dx.doi.org/10.3389/fendo.2020.00500.
  17. Министерство здравоохранения Российской Федерации. Клинические рекомендации «Женское бесплодие». 2021. [Ministry of Health of the Russian Federation. Clinical Guidelines “Women’s Infertility”. 2021. (in Russian)].
  18. Labarta E., Mariani G., Rodríguez-Varela C., Bosch E. Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles. Fertil. Steril. 2022; 117(1): 96-103. https://dx.doi.org/10.1016/ j.fertnstert.2021.08.040.
  19. Tavaniotou A., Smitz J., Bourgain C., Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum. Reprod. Update. 2000; 6(2): 139-48. https://dx.doi.org/10.1093/humupd/6.2.139.
  20. Shiba R., Kinutani M., Okano S., Kawano R., Kikkawa Y. Efficacy of four vaginal progesterones for luteal phase support in frozen-thawed embryo transfer cycles: A randomized clinical trial. Reprod. Med. Biol. 2019; 19(1): 42-9. https://dx.doi.org/10.1002/rmb2.12300.
  21. Государственный реестр лекарственных средств РФ (ГРЛС). Инструкция по медицинскому применению препарата «Миражэль» [State Register of Medicines of the Russian Federation (GRLS). Instructions for the medical use of the drug «Miragel» (in Russian)]. https://grls.rosminzdrav.ru/ Grls_View_v2.aspx?routingGuid=461e642f-e5e1-4af5-8e50-a7f25d670abd
  22. Simunic V., Tomic V., Tomic J., Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil. Steril. 2007; 87(1): 83-7. https://dx.doi.org/10.1016/j.fertnstert.2006.05.067. Erratum in: Fertil. Steril. 2007; 88(1): 254.
  23. Фармацевтическая компания «Вертекс». Информационное письмо №521 от 21.11.2023. [Pharmaceutical company «Vertex». Information letter No.521 dated 11/21/2023. (in Russian)]. https://vertex.spb.ru/upload/medialibrary/d70/e2hdrwmv8y2l6ro0lk6v6vanx5ipg9dj.pdf
  24. Тапильская Н.И., Гзгзян А.М., Коган И.Ю., Писарев В.В., Меркулов М.Е., Корнеева И.Е. Сравнительные фармакокинетические свойства и оценка безопасности воспроизведенного препарата прогестерона в форме вагинального геля: результаты открытого рандомизированного перекрестного исследования биоэквивалентности. Акушерство и гинекология. 2022; 8: 144-52. [Tapilskaya N.I., Gzgzyan А.М., Kоgan I.Yu., Pisarev V.V., Merkulov М.Е., Korneeva I.E. Pharmacokinetic properties and safety assessment of the generic vaginal gel progesterone preparation: results of an open-label, randomized, crossover bioequivalence study. Obstetrics and Gynecology. 2022; (8): 144-52 (in Russian)]. https://dx.doi.org/10.18565/ aig.2022.8.144-152.
  25. Маясина Е.Н., Буев Ю.Е., Аскеров Р.А., Ямалыева Н.Ш., Кичигина Е.А., Корнилова А.С., Салимов Д.Ф. Сравнительный анализ эффективности вагинальных форм прогестерона в программах экстракорпорального оплодотворения. Проблемы репродукции. 2023; 29(5): 54-9. [Mayasina E.N., Buev Yu.E., Askerov R.A., Yamalyeva N.Sh., Kichigina E.A., Kornilova A.S., Salimov D.F. Comparative analysis of the effectiveness of vaginal forms of progesterone in IVF programs. Russian Journal of Human Reproduction. 2023; 29(5): 54-9. (in Russian)]. https://doi.org/10.17116/ repro20232905154.
  26. Кедрова А.Г., Леваков С.А., Челнокова Н.Н., Ванке Н.С., Нечаева О.Е. Новые подходы к лечению простой гиперплазии эндометрия у женщин с предменструальным синдромом. Вопросы гинекологии, акушерства и перинатологии. 2014;13(1):22-9. [Kedrova A.G., Levakov S.A., Chelnokova N.N., Vanke N.S., Nechaeva O.E. New approaches to treatment of simple endometrial hyperplasia in women with premenstrual syndrome. Gynecology, Obstetrics and Perinatology. 2014;13(1):22-9. (in Russian)].
  27. Средние цены в аптеках г. Москвы по данным агрегатора Ютека на 17.01.2024. [Average prices in pharmacies in Moscow according to the aggregator Yuteka on 17.01.2024. (in Russian)]. https://uteka.ru/catalog/

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2024
##common.cookie##